Recombinant human endostatin protein

Recombinant human endostatin protein
Trade Name
Orphan Indication Neuroendocrine tumors
USA Market Approval USA
USA Designation Date 2001-08-13 00:00:00
Sponsor EntreMed, Inc.;9640 Medical Center Drive;Rockville, Maryland, 20850
Related Access Program
Advanced Accelerator Applications – Neuroendocrine Tumors Andrei Iagaru – Other Neuroendocrine Tumors Jonsson Comprehensive Cancer Center – Neuroendocrine Tumors Memorial Sloan Kettering Cancer Center. – Neuroendocrine Tumors